State Street’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-151,871
Closed -$1.1M 3875
2019
Q2
$1.1M Sell
151,871
-42,105
-22% -$287K ﹤0.01% 3404
2019
Q1
$1.28M Buy
193,976
+20,885
+12% +$138K ﹤0.01% 3286
2018
Q4
$1.24M Sell
173,091
-21,720
-11% -$242K ﹤0.01% 3274
2018
Q3
$3.72M Sell
194,811
-31,684
-14% -$1.13M ﹤0.01% 3002
2018
Q2
$12.8M Buy
226,495
+45,268
+25% +$2.3M ﹤0.01% 2419
2018
Q1
$7.67M Sell
181,227
-28,642
-14% -$1.23M ﹤0.01% 2590
2017
Q4
$11.2M Buy
209,869
+33,003
+19% +$1.74M ﹤0.01% 2414
2017
Q3
$7.89M Sell
176,866
-18,277
-9% -$833K ﹤0.01% 2552
2017
Q2
$9.48M Buy
195,143
+20,170
+12% +$1.19M ﹤0.01% 2420
2017
Q1
$12.7M Buy
174,973
+18,763
+12% +$1.24M ﹤0.01% 2239
2016
Q4
$8.94M Buy
156,210
+11,541
+8% +$1.06M ﹤0.01% 2403
2016
Q3
$18.5M Buy
144,669
+11,239
+8% +$1.44M ﹤0.01% 1824
2016
Q2
$16.6M Buy
133,430
+8,236
+7% +$947K ﹤0.01% 1882
2016
Q1
$10.5M Buy
125,194
+7,579
+6% +$625K ﹤0.01% 2142
2015
Q4
$11.7M Buy
117,615
+4,510
+4% +$483K ﹤0.01% 2091
2015
Q3
$13.9M Sell
113,105
-532
-0.5% -$72.2K ﹤0.01% 1987
2015
Q2
$17.4M Buy
113,637
+2,988
+3% +$493K ﹤0.01% 1943
2015
Q1
$18.9M Buy
110,649
+848
+0.8% +$128K ﹤0.01% 1883
2014
Q4
$16.8M Buy
109,801
+2,693
+3% +$336K ﹤0.01% 1915
2014
Q3
$11.3M Sell
107,108
-2,104
-2% -$293K ﹤0.01% 2109
2014
Q2
$16.6M Sell
109,212
-3,563
-3% -$474K ﹤0.01% 1934
2014
Q1
$14.5M Buy
112,775
+3,493
+3% +$543K ﹤0.01% 1989
2013
Q4
$19.1M Buy
109,282
+3,876
+4% +$666K ﹤0.01% 1784
2013
Q3
$17M Buy
105,406
+6,785
+7% +$1.07M ﹤0.01% 1803
2013
Q2
$13.1M Buy
+98,621
New +$13.9M ﹤0.01% 1896

Other funds holding ELGX

State Street's ELGX Position: Q3 2019 in Review

State Street sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 151,871 shares — an estimated $1.1M sold.

State Street first reported a position in ELGX in Q2 2013 and held it in 25 quarters. The position peaked at $19.1M in Q4 2013. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • State Street reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • State Street sold 151,871 Endologix Inc shares in Q3 2019, an estimated $1.1M.
  • State Street first reported a position in Endologix Inc in Q2 2013 and held it in 25 quarters.
  • State Street's Endologix Inc position peaked at $19.1M in Q4 2013.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on State Street's 13F filing for Q3 2019, filed 14 Nov 2019.